LPL Financial
CTMX icon

LPL Financial’s CytomX Therapeutics CTMX Stock Holding History

LPL Financial’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Buy
171,733
+49,099
+40% +$187K ﹤0.01% 4799
2026
Q1 		$576K Buy
122,634
+9,194
+8% +$46.7K ﹤0.01% 4635
2025
Q4 		$483K Buy
113,440
+26,787
+31% +$102K ﹤0.01% 4746
2025
Q3 		$276K Sell
86,653
-114,571
-57% -$258K ﹤0.01% 5111
2025
Q2 		$457K Buy
201,224
+158,909
+376% +$256K ﹤0.01% 4452
2025
Q1 		$26.9K Hold
42,315
– – ﹤0.01% 5222
2024
Q4 		$43.6K Buy
42,315
+4,000
+10% +$4.3K ﹤0.01% 5115
2024
Q3 		$45.2K Buy
38,315
+2,000
+6% +$2.54K ﹤0.01% 5009
2024
Q2 		$44.3K Sell
36,315
-56,000
-61% -$111K ﹤0.01% 4854
2024
Q1 		$201K Sell
92,315
-17,950
-16% -$33.1K ﹤0.01% 4507
2023
Q4 		$171K Buy
110,265
+4,873
+5% +$6.41K ﹤0.01% 4435
2023
Q3 		$136K Buy
105,392
+7,127
+7% +$11.2K ﹤0.01% 4357
2023
Q2 		$169K Buy
98,265
+39,500
+67% +$65.6K ﹤0.01% 4206
2023
Q1 		$88.7K Hold
58,765
– – ﹤0.01% 4229
2022
Q4 		$94K Buy
58,765
+3,000
+5% +$4.44K ﹤0.01% 4184
2022
Q3 		$81K Buy
55,765
+21,025
+61% +$32.4K ﹤0.01% 4155
2022
Q2 		$64K Buy
+34,740
New +$66.5K ﹤0.01% 4199
2021
Q4 		– Sell
-19,075
Closed -$97K – 4362
2021
Q3 		$97K Sell
19,075
-10,325
-35% -$55.3K ﹤0.01% 4151
2021
Q2 		$186K Buy
29,400
+6,500
+28% +$50.6K ﹤0.01% 3924
2021
Q1 		$177K Buy
+22,900
New +$181K ﹤0.01% 3801

Other funds holding CTMX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AGP
Aspire Growth Partners Miromar Lakes, Florida $172M AUM 33.61% 1-Year Est. Return

LPL Financial's CTMX Position: Q2 2026 in Review

LPL Financial increased its CytomX Therapeutics (CTMX) stake by 40% in Q2 2026, buying an estimated $187K and bringing the position to 171,733 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #4799.

LPL Financial first reported a position in CTMX in Q1 2021 and has held it in 20 quarters since. 44 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • LPL Financial held 171,733 shares of CytomX Therapeutics worth $644K as of Q2 2026.
  • LPL Financial bought 49,099 CytomX Therapeutics shares in Q2 2026, an estimated $187K.
  • CytomX Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4799 holding.
  • LPL Financial first reported a position in CytomX Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • 44 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.